NeoVentures Biotechnology Inc

About NeoVentures Biotechnology Inc

NeoVentures Biotechnology Inc. is an aptamer company located on York Street in the Downtown neighbourhood of London, Ontario. The business serves clients looking to identify and develop aptamers for commercial applications, specifically within the fields of therapeutics, diagnostics, and drug development. The company offers specialized consulting services to help clients design and evaluate aptamer selection strategies, interpret experimental results, and integrate aptamers into biosensor or assay platforms. They utilize the Neomer selection method, which they describe as an innovative solution to the limitations of SELEX. Their process includes project design, selection of aptamers using NGS analysis, validation and optimization of sequences, and ongoing product concept support through the patent process, FDA approval, and CE mark. Clients who partner with the company fully own the generated aptamers without royalty obligations or licensing fees. Founded in 2002 by Dr. Gregory Penner and Ximena Vedoya, the company was established to apply innovative approaches to improving healthcare. The business describes itself as a collective of scientists driven by the goal of reinventing healthcare through aptamer technology. They emphasize a collaborative approach, building dynamic partnerships rather than selling pre-set development packages. Consulting services are provided on a flexible month-to-month basis and include weekly or bi-weekly meetings, direct access to the scientific team, and written feedback. The company provides free consultations and offers information in English, French, and Spanish.